论文部分内容阅读
目的对肝硬化难治性腹水临床治疗效果展开对比分析。方法 54例肝硬化难治性腹水患者随机分为治疗组和对照组,各27例。患者均经常规治疗方法进行治疗,在此基础上,对照组患者静脉滴注白蛋白治疗,治疗组患者行腹穿抽液术+静脉滴注白蛋白和右旋糖酐40进行治疗,比较两组患者临床治疗效果。结果治疗组患者临床治疗总有效率、平均尿量和平均住院时间分别为81.48%、(607.52±51.13)ml、(9.02±1.14)d,与对照组的59.26%、(378.59±50.02)ml、(20.03±2.32)d比较,差异有统计学意义(P<0.05)。结论在治疗肝硬化难治性腹水临床上腹穿抽液术+静脉滴注白蛋白和右旋糖酐40效果较为理想。
Objective To compare and analyze the clinical effect of refractory ascites due to cirrhosis. Methods 54 patients with cirrhosis and refractory ascites were randomly divided into treatment group and control group, with 27 cases in each group. Patients were treated by conventional treatment methods, on this basis, the control group patients intravenous albumin treatment, patients in the treatment group were abdominal paracentesis + intravenous albumin and dextran 40 for treatment, the two groups of patients were compared treatment effect. Results The total effective rate, average urine output and average length of stay of patients in the treatment group were 81.48%, 607.52 ± 51.13 ml and 9.02 ± 1.14 d, respectively, which were significantly higher than those in the control group (59.26%, 378.59 ± 50.02) ml, (20.03 ± 2.32) d, the difference was statistically significant (P <0.05). Conclusions In the treatment of refractory ascites cirrhosis clinical paracentesis + intravenous infusion of albumin and dextran 40 results are more satisfactory.